CBD Innovator, HempFusion, Makes Successful Debut on TSX


Ryan Allway

January 13th, 2021

App, Exclusive, News, Top Story


 

HempFusion Wellness Inc. (TSX: CBD-U) shares soared over 65% following their successful debut on the Toronto Stock Exchange (TSX) on Wednesday, January 6, 2021.

Cannabidiol, or CBD, has become one of the most popular health and wellness products in the world over the past couple of years. According to Research and Markets, the global CBD market will grow at 25.6% to $123.2 billion by 2027, driven by growing buyer awareness and regulatory support over the past several years.

While the market has become saturated with thousands of brands, HempFusion’s focus on compliance may set it apart from the competition. The company combined DNA-verified organic industrial hemp sourced from European farms with its regulatory expertise to launch FDA OTC Drug Listed topicals capable of making certain health claims.

Click here to receive an investor presentation and corporate updates

HempFusion already has products available in mainstream retailers, including Sprouts Farmers Markets, Whole Foods, and the Vitamin Shoppe, as well as online and through Amazon.com. The company has plans to target expansion and distribution to over 10,000 retail locations, including mass-market (FDM) retail, convenience channels, and doctor/practitioner networks complemented by  a robust focus on ecommerce and Amazon online expansion.

Moving Toward Regulation

Cannabis and hemp have a checkered past when it comes to government regulations, but most in the industry acknowledge the need for regulations. In addition to improving consumer safety and trust, official regulations could replace the patchwork of confusing rules surrounding hemp, including the DEA’s classification system.  

That said, the Food and Drug Administration (FDA) has recognized the potential opportunities that cannabis and cannabis-derived compounds may offer and acknowledged significant interest in those possibilities. The agency has been increasingly receptive to working with the industry but requires more data before it can provide broader guidance.

The CBD industry has been working to address many of the agency’s concerns. For instance, HempFusion recently teamed up with ValidCare as a co-sponsor and co-funding, with a handful of other CBD companies to participate in what is believed to be the largest human observational industry-wide study measuring the effects of full-spectrum hemp-derived CBD and CBD isolate on the liver—a large toxicity concern for the FDA and other regulators.

“We are very proud to be co-funding / co-sponsoring this wide-scale human toxicology study” commented  Co-Founder and CEO of HempFusion Jason Mitchell, N.D…..” and we believe that it is our responsibility as companies selling products that contain CBD, to show that it is safe.” 

The impact of these regulations is likely to vary between companies. For instance, compliance-focused companies like HempFusion may be better positioned to benefit from the new rules whereas less scrupulous companies could suffer from a crackdown on unsafe or low-quality products that could undermine consumer confidence.

Click here to receive an investor presentation and corporate updates

Investors Seek Exposure

HempFusion’s successful debut on the TSX underscores the investor interest in CBD companies and follows the success of Charlotte’s Web Holdings Inc. (TSX: CWEB)—which has risen about 30% since the beginning of the year—and other established companies in the space. These trends don’t appear ready to reverse as consumer interest in CBD continues to grow.

HempFusion believes it is well-positioned to continue its growth over the coming quarters with a focus on building out its retail and distribution footprint. With a unique competitive advantage over generic products, the company could have durable margins as the industry continues to grow and ultimately benefit when the FDA releases formal industry guidelines.

Click here to receive an investor presentation and corporate updates

Disclaimer

The above article is sponsored content. CannabisFN.com and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/  

CannabisFN.com and CFN Media, have been hired by HempFusion to create awareness.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

Ryan Allway

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading